Development of a pain intensity estimation model in breast cancer survivors using quantile regression: A nationwide claims-based cohort study
Int. Journal of Clinical Pharmacology and Therapeutics · 01.08.2026 · 64 (08) · 391-397
DOI: 10.5414/cp204804 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.08.2026. Verfasst von Jin Lee und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Breast Neoplasms, Pain Measurement, Cancer Survivors, Cancer Pain.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Lee, J., Chan, A., Cho, J., & Seo, H. J. (2026). Development of a pain intensity estimation model in breast cancer survivors using quantile regression: A nationwide claims-based cohort study. Int. Journal of Clinical Pharmacology and Therapeutics, 64(08), 391-397. https://doi.org/10.5414/cp204804
Vancouver
Lee J, Chan A, Cho J, Seo HJ. Development of a pain intensity estimation model in breast cancer survivors using quantile regression: A nationwide claims-based cohort study. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(08):391-397. doi:10.5414/cp204804
BibTeX
@article{Lee2026,
author = {Lee, Jin and Chan, Alexsandre and Cho, Juhee and Seo, Hwa Jeong},
title = {Development of a pain intensity estimation model in breast cancer survivors using quantile regression: A nationwide claims-based cohort study},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {08},
pages = {391--397},
doi = {10.5414/cp204804}
}
EUVIMED